Back
ProQR Therapeutics NV Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
PRQR
ProQR Therapeutics NV
Last Price:
3.63
Seasonality Move:
8.38%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- The current trend is moderately bullish and PRQR is experiencing slight selling pressure.
ProQR Therapeutics NV Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.74 | Sell |
| 20-day SMA: | 3.68 | Sell |
| 50-day SMA: | 2.84 | Buy |
| 200-day SMA: | 2.19 | Buy |
| 8-day EMA: | 3.69 | Sell |
| 20-day EMA: | 3.58 | Buy |
| 50-day EMA: | 3.08 | Buy |
| 200-day EMA: | 2.33 | Buy |
ProQR Therapeutics NV Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 54.6 | Buy |
| Chaikin Money Flow: | -35463 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.49 - 3.87) | Sell |
| Bollinger Bands (100): | (1.55 - 3.21) | Buy |
ProQR Therapeutics NV Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProQR Therapeutics NV Stock
Is ProQR Therapeutics NV Stock a Buy?
- ProQR Therapeutics NV share price is 3.62 while PRQR 8-day simple moving average is 3.74, which is a Sell signal.
- The stock price of PRQR is 3.62 while ProQR Therapeutics NV 20-day SMA is 3.68, which makes it a Sell.
- ProQR Therapeutics NV 50-day simple moving average is 2.84 while PRQR share price is 3.62, making it a Buy technically.
- PRQR stock price is 3.62 and ProQR Therapeutics NV 200-day simple moving average is 2.19, creating a Buy signal.
PRQR Technical Analysis vs Fundamental Analysis
Buy
51
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy or a Sell?
-
ProQR Therapeutics NV stock is rated a Buy
The current ProQR Therapeutics NV [PRQR] share price is $3.62. The Score for PRQR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
ProQR Therapeutics NV Stock Info
Market Cap:
383.38M
Price in USD:
3.62
Share Volume:
390.09K
ProQR Therapeutics NV 52-Week Range
52-Week High:
4.62
52-Week Low:
1.18
Buy
51
ProQR Therapeutics NV (PRQR)
is a Buy
ProQR Therapeutics NV Share Price Forecast
-
What is the ProQR Therapeutics NV stock price today?
The ProQR Therapeutics NV stock price is 3.62 USD today. -
Will PRQR stock go up or go down?
ProQR Therapeutics NV> share price is forecast to RISE/FALL based on technical indicators -
Is ProQR Therapeutics NV overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProQR Therapeutics NV is not overvalued.
Is ProQR Therapeutics NV Stock a Buy?
- ProQR Therapeutics NV share price is 3.62 while PRQR 8-day exponential moving average is 3.69, which is a Sell signal.
- The stock price of PRQR is 3.62 while ProQR Therapeutics NV 20-day EMA is 3.58, which makes it a Buy.
- ProQR Therapeutics NV 50-day exponential moving average is 3.08 while PRQR share price is 3.62, making it a Buy technically.
- PRQR stock price is 3.62 and ProQR Therapeutics NV 200-day simple moving average is 2.33, creating a Buy signal.
Fundamental Analysis of ProQR Therapeutics NV
Is ProQR Therapeutics NV a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
Technical Analysis of ProQR Therapeutics NV
Should I short ProQR Therapeutics NV stock?
- PRQR Moving Average Covergence Divergence (MACD) indicator is 0.21, suggesting ProQR Therapeutics NV is a Buy
- ProQR Therapeutics NV Relative Strength Index (RSI) is 54.6, which suggest ProQR Therapeutics NV is overbought
- The Bollinger Bands (25) for ProQR Therapeutics NV is (3.49 - 3.87), which suggest ProQR Therapeutics NV is a Buy
- The Bollinger Bands (100) for ProQR Therapeutics NV is (1.55 - 3.21), which suggest ProQR Therapeutics NV is a Buy
* ProQR Therapeutics NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.